Understanding and modulating hyperinflammation caused by influenza viruses

Tate, Michelle (Primary Chief Investigator (PCI))

Hudson Institute - Centre for Innate Immunity and Infectious Disease

Project: Research

Status	Finished
Effective start/end date	1/01/17 → 30/09/21

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$425,048.00

5 Article

Interleukin-1β exacerbates disease and is a potential therapeutic target to reduce pulmonary inflammation during severe influenza A virus infection
Bawazeer, A. O. S., Rosli, S., Harpur, C. M., Docherty, C. A. H., Mansell, A. & Tate, M. D., Aug 2021, In: Immunology and Cell Biology. 99, 7, p. 737-748 12 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

4 Citations (Scopus)
Too young to die? How aging affects cellular innate immune responses to influenza virus and disease severity
Harpur, C. M., Le Page, M. A. & Tate, M. D., 21 Jun 2021, In: Virulence. 12, 1, p. 1629-1646 18 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

1 Citation (Scopus)
Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection
Rosli, S., Kirby, F. J., Lawlor, K. E., Rainczuk, K., Drummond, G. R., Mansell, A. & Tate, M. D., Oct 2019, In: British Journal of Pharmacology. 176, 19, p. 3834-3844 11 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

26 Citations (Scopus)